A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients-Reference-Cited by-同舟云学术

A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients

Published:2014-09 Issue:S6 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Phelan Maria,Cook Catherine

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/1471-2334-14-S6-S5.pdf

Reference31 articles.

1. Bosely S: New hepatitis C drugs must be affordable worldwide, say campaigners. Guardian Newspaper. 2014, In press [ http://www.theguardian.com/society/sarah-boseley-global-health/2014/mar/17/hepatitis-c-pharmaceuticals-industry ]

2. Hanafiah Modh K, et al: Global Epidemiology of Hepatitis C Virus Infection: New Estimates of Age-Specific Antibody to HCV. Seroprevalence Hepatology. 2013, 57: 1333-1342. 10.1002/hep.26141.

3. UNAIDS/WHO/UNICEF: Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report. 2008, Geneva

4. Nelson PK, et al: Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378 (9791): 571-583. 10.1016/S0140-6736(11)61097-0.

5. Soriano V, et al: Viral hepatitis and HIV co-infection. Antiviral Research. 2008, 85 (1): 303-315.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variables affecting new drug prices in South Korea’s pricing system;Frontiers in Pharmacology;2024-05-09

2. Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs;JAMA Health Forum;2024-04-05

3. Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook;Drug Discovery Today;2023-01

4. Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions;Expert Review of Pharmacoeconomics & Outcomes Research;2022-04-04

5. Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy;Frontiers in Pharmacology;2020-11-13